Scarica l'app Stockscreener
26.43
2.24%
0.58
Pre-mercato:
26.55
0.12
+0.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
Here’s why Pfizer is revising its revenue forecasts - MarketWatch
Pfizer stock edges higher on 2026 guidance. Expect a rough year for Covid vaccine sales - MSN
Pfizer forecasts lower EPS, flat sales in 2026 - Sherwood News
Pfizer forecasts 2026 profit below expectations on lower COVID product sales - MSN
Pfizer Updates 2025 Revenue Guidance, Issues 2026 Outlook - marketscreener.com
Pfizer Revises 2025 Revenue Guidance to $62 Billion - TipRanks
Pfizer: Can $108B Bet on Obesity Drugs Revive Its Struggling Stock? - Investing.com
Pfizer projects 2026 revenue of $59.5-62.5 billion, adjusts 2025 outlook By Investing.com - Investing.com South Africa
Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales. - Barron's
Shorepoint Capital Partners LLC Invests $3.06 Million in Pfizer Inc. $PFE - MarketBeat
Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings - The Wall Street Journal
Pfizer reaffirms 2025 earnings guidance (PFE:NYSE) - Seeking Alpha
Pfizer Adds to Its Big Bet on Weight Loss Drugs - Finviz
Pfizer Forecasts Flat 2026 Sales as It Builds Drug Pipeline - Bloomberg.com
Pfizer expects 2026 sales of $59.5 to $62.5 billion - breakingthenews.net
Pfizer reaffirms full-year 2025 EPS guidance and provides full-year 2026 guidance - marketscreener.com
Pfizer projects 2026 revenue of $59.5-62.5 billion, adjusts 2025 outlook - Investing.com
Pfizer forecasts 2026 profit below expectations - marketscreener.com
Pfizer shares fall 1.6% premarket after co releases fy2026 forecasts - marketscreener.com
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance - The AI Journal
Texas Permanent School Fund Corp Sells 213,755 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Stock (PFE) Today, Dec. 16, 2025: 2026 Guidance Call Looms as Analysts Weigh Dividend, Deal Flow, and Policy Risks - ts2.tech
Caldwell Trust Co Takes $1.28 Million Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Stock After Hours (PFE) on Dec. 15, 2025: What Moved Shares Today—and What to Watch Before Tuesday’s Open - ts2.tech
Pfizer (NYSE:PFE) Stock Price Up 2.3% After Dividend Announcement - MarketBeat
Pfizer (PFE) Valuation Check After Positive Phase 3 Wins and New Obesity Drug Licensing Deal - simplywall.st
Pfizer Stock (PFE) News, Forecasts, and Analyst Outlook: What’s Driving Shares on December 15, 2025 - ts2.tech
What's Going On With Pfizer Stock Monday?Pfizer (NYSE:PFE) - Benzinga
Adaptive signs deal with Pfizer worth up to $890 million for rheumatoid arthritis research - Reuters
Adaptive Biotechnologies inks two agreements with Pfizer in immunology - Investing.com
Adaptive Biotechnologies inks two agreements with Pfizer in immunology By Investing.com - Investing.com UK
Adaptive Biotechnologies stock rises after Pfizer deals worth up to $890M - Investing.com Canada
Adaptive Biotechnologies stock rises after Pfizer deals worth up to $890M By Investing.com - Investing.com South Africa
Adaptive Biotechnologies announces two immune receptor licensing agreements with Pfizer - PharmaLive
Adaptive Biotechnologies signs two immune receptor licensing deals with Pfizer - marketscreener.com
Watts Gwilliam & Co. LLC Buys 50,744 Shares of Pfizer Inc. $PFE - MarketBeat
Adaptive Biotechnologies Signs Target Discovery, Licensing Deals With Pfizer - marketscreener.com
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know - Yahoo Finance
ANALYSIS: Novo’s Novel GLP-1 Bid Failed But That’s Not the Point - Bloomberg Law News
Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million - marketscreener.com
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer - GlobeNewswire
Pfizer Stock (PFE) News Today: Dividend, 2026 Guidance Call, Obesity Deals, and Analyst Forecasts (Dec. 15, 2025) - ts2.tech
Pfizer’s Hold Rating: Navigating Loss of Exclusivity and Flat Growth Prospects - TipRanks
47,996 Shares in Pfizer Inc. $PFE Acquired by MASTERINVEST Kapitalanlage GmbH - MarketBeat
Marex Group plc Purchases Shares of 65,461 Pfizer Inc. $PFE - MarketBeat
Pfizer Declares First-Quarter 2026 Dividend - BioSpace
Cullen Capital Management LLC Has $88.32 Million Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Stock (PFE) News and Forecast for Dec. 14, 2025: Dividend, Obesity Deal, Oncology Catalysts, and What Analysts Expect Next - ts2.tech
Pfizer Stock (PFE) Before Market Open Dec. 15, 2025: Key News, 2026 Guidance Call, Analyst Targets, Dividend, and Risks - ts2.tech
Pfizer’s New Phase 1 Study: A Potential Breakthrough for Kidney Disease Treatment - TipRanks
Orion Porfolio Solutions LLC Has $17.19 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Pfizer Stock (PFE) Outlook: This Week’s Key Headlines, Dividend Update, and What to Watch Ahead of 2026 Guidance (Updated Dec. 14, 2025) - ts2.tech
Evergreen Capital Management LLC Purchases 63,611 Shares of Pfizer Inc. $PFE - MarketBeat
Forget Teladoc and Buy This Healthcare Stock Instead - Yahoo Finance
Beddow Capital Management Inc. Cuts Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Bellevue Group AG Reduces Holdings in Pfizer Inc. $PFE - MarketBeat
Banque Transatlantique SA Lowers Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Purchased by Adage Capital Partners GP L.L.C. - MarketBeat
Pfizer (PFE) Stock After Hours on Dec. 12, 2025: Dividend Update, FDA “Black Box” Headline, Analyst Forecasts — What to Know Before the Next Market Open - ts2.tech
Pfizer (PFE) Stock After Hours on Dec. 12, 2025: Dividend Update, FDA Vaccine Warning Headlines, and What to Watch Before the Next Market Open - ts2.tech
Pfizer Inc. Declares First-Quarter 2026 Dividend, Payable on March 6, 2026 - marketscreener.com
Pfizer declares $0.43 quarterly dividend payable in March 2026 - Investing.com
Pfizer declares $0.43 quarterly dividend payable in March 2026 By Investing.com - Investing.com Canada
Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. - The Globe and Mail
The Best Turnaround Stock to Invest $1,000 in Right Now - Finviz
Is Pfizer Shifting From Defensive Stock To Value Opportunity After Post Pandemic Restructuring? - simplywall.st
Treasurer of the State of North Carolina Purchases 520,580 Shares of Pfizer Inc. $PFE - MarketBeat
0.51%
2.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):